对布鲁顿的氨酸激酶与非共价抑制剂的突变诱导的结合变化进行计算洞察
Justice Josiah Mallen1, Shilpa Sharma1, Md Nazmul Hasan1
1Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA.
Journal of biomolecular structure & dynamics
|May 15, 2025
概括
布鲁顿的氨酸激酶 (BTK) 突变降低了慢性淋巴细胞白血病 (CLL) 的非共价抑制剂疗效. 这项研究揭示了这些突变如何破坏药物结合,为下一代BTK抑制剂提供了洞察力,以克服耐药性.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 基因酶调节信号通路;失调与癌症等疾病有关.
- 布鲁顿的氨酸激酶 (BTK) 对B细胞发育至关重要,也是B细胞恶性瘤的点.
- 非共价BTK抑制剂是有效的,但由于突变而面临耐药性.
研究的目的:
- 研究四种普遍存在的BTK催化域突变 (A428D,T474I,C481S,L528W) 对非共价抑制剂结合的影响.
- 了解BTK突变癌症中耐药性背后的分子机制.
- 告知下一代BTK抑制剂的设计,以克服耐药性.
主要方法:
- 利用了12.5微秒的分子动力学模拟.
- 采用计算药物发现技术.
- 进行了分子力学Poisson-Boltzmann表面积 (MM-PBSA) 分析.
- 分析了结合口袋体积和溶剂可访问的表面积.
主要成果:
- 与野生型相比,突变的BTK形式显著减少了连接体结合的自由能量.
- 突变减少了结合口袋体积,取代了抑制剂.
- 观察到抑制剂和突变BTK之间的关键非共价相互作用的破坏.
- 这些发现证实了实验和临床观察中关于抑制剂功效受损的证据.
结论:
- 催化域中的BTK突变是对非共价抑制剂耐药性的关键机制.
- 改变的结合口袋动态和减少的结合亲和力解释了治疗失败.
- 结果为开发新型BTK抑制剂提供了关键的见解,以对抗B细胞恶性瘤中抗药性.
相关概念视频
Covalently Linked Protein Regulators
6.7K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.7K
The Equilibrium Binding Constant and Binding Strength
12.7K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.7K
Ligand Binding and Linkage
4.7K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.7K
Conserved Binding Sites
4.1K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.1K
Ligand Binding Sites
12.6K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.6K
Allosteric Regulation
57.2K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
57.2K


